FINWIRES · TerminalLIVE
FINWIRES

Chongqing Taiji Industry Gets China Nod for Diabetes Tablets

By

China's drug regulator approved the metformin empagliflozin tablets produced by Chongqing Taiji Industry (SHA:600129) subsidiary Southwest Pharmaceutical, according to a Thursday filing with the Shanghai bourse.

The drug is used to control blood sugar in type 2 diabetes patients.

Related Articles